Metabolic reprogramming: A novel metabolic model for pulmonary hypertension

Pulmonary arterial hypertension, or PAH, is a condition that is characterized by pulmonary artery pressures above 20 mmHg (at rest). In the treatment of PAH, the pulmonary vascular system is regulated to ensure a diastolic and contraction balance; nevertheless, this treatment does not prevent or rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xuhan, Zhang, Liping, Zhang, Weihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458918/
https://www.ncbi.nlm.nih.gov/pubmed/36093148
http://dx.doi.org/10.3389/fcvm.2022.957524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458918/
https://www.ncbi.nlm.nih.gov/pubmed/36093148
http://dx.doi.org/10.3389/fcvm.2022.957524

Ejemplares similares